Novartis Says Drug Helps Children With Spinal Atrophy in Study

Estimated read time 1 min read


Novartis AG said a new experimental medicine improved motor function in children with a form of spinal muscular atrophy, the devastating disorder targeted by its gene therapy Zolgensma, in an advanced study.

Source link

You May Also Like

More From Author

+ There are no comments

Add yours